What is the treatment for foot fungus, specifically athlete's foot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Foot Fungus (Athlete's Foot)

For athlete's foot (tinea pedis), apply topical terbinafine 1% cream twice daily for 1 week for infection between the toes, or twice daily for 2 weeks for infection on the bottom or sides of the foot. 1

First-Line Topical Treatment

  • Terbinafine 1% cream is the most effective topical agent, achieving 66% effective cure rate with twice-daily application for just 1 week for interdigital disease—superior to longer courses of other antifungals. 2

  • For interdigital (between-toes) tinea pedis: Apply terbinafine 1% cream twice daily (morning and night) for 1 week. 1

  • For plantar (bottom or sides of foot) tinea pedis: Apply terbinafine 1% cream twice daily for 2 weeks. 1

  • Alternative topical option: Ciclopirox olamine 0.77% cream/gel applied twice daily for 4 weeks achieves 60% cure at end of treatment and 85% cure two weeks post-treatment, making it superior to clotrimazole 1%. 2

  • Clotrimazole 1% cream is less effective than terbinafine but widely available over-the-counter. 3

When to Use Oral Therapy

Reserve oral antifungals for severe disease, failed topical therapy, concomitant toenail fungus (onychomycosis), or immunocompromised patients. 3

Oral Treatment Options:

  • Terbinafine 250 mg once daily for 1-2 weeks is the most effective oral treatment, providing faster clinical resolution than topical treatments and superior efficacy against dermatophytes. 2, 3

  • Itraconazole 100 mg daily for 2 weeks has similar mycological efficacy to terbinafine but may have slightly higher relapse rates. 2

  • Fluconazole is less effective than both terbinafine and itraconazole but may be useful when other agents are contraindicated due to fewer drug interactions. 3

Essential Prevention Measures

  • Thoroughly dry between toes after showering—moisture promotes fungal growth. 2

  • Change socks daily and clean athletic footwear periodically. 2

  • Apply foot powder after bathing, which can reduce tinea pedis rates from 8.5% to 2.1%. 3

  • Wear well-fitting, ventilated shoes and absorbent cotton socks. 1

  • Cover active foot lesions with socks before wearing underwear to prevent spread to the groin area. 2

Critical Pitfalls to Avoid

  • Failing to treat all infected family members simultaneously results in reinfection. 3

  • Neglecting contaminated footwear as a source of reinfection leads to recurrence—address this by cleaning athletic shoes periodically. 3

  • Do not share towels, clothing, or personal items, as these fomites transmit infection. 2

  • If infection has not resolved after 4 weeks of apparently appropriate therapy, re-evaluate and reconsider diagnostic studies or alternative treatments. 4

Special Populations

  • For diabetic patients, prefer terbinafine over itraconazole due to lower risk of drug interactions and hypoglycemia—up to one-third of diabetics have onychomycosis, which significantly predicts foot ulcer development. 3

  • In persons with diabetes at risk of foot ulceration, prescribe anti-fungal treatment for fungal infections to help prevent foot ulcers. 4

  • Athletes require minimum 72 hours of antifungal therapy before return to contact sports, with lesions covered appropriately. 3

  • For children under 12 years: consult a physician before treatment. 1

Risk Factors

Risk factors include swimming, running, warm humid environments, male gender, obesity, and diabetes. 2, 3

References

Guideline

Management of Tinea Corporis and Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Tinea Pedis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.